Causal Relationship between Inflammatory Proteins and Alzheimer's Disease: A Two-Sample Bidirectional Mendelian
1Chengdu Sixth People's Hospital, Chengdu, China, 383185839@qq.com.
Higher levels of tumor necrosis factor-beta (TNF-β) and interleukin-6 (IL-6) may reduce Alzheimer's disease (AD) risk. This study used a bidirectional Mendelian randomization approach to investigate the causal links between inflammatory proteins and AD. The findings suggest a protective role for these specific inflammatory proteins against AD development.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Neuroinflammation is a key driver of neurodegeneration in Alzheimer's disease (AD).
- Protein aggregation in AD can exacerbate neuroinflammation and neurodegeneration.
- Understanding the causal relationship between inflammation and AD is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To investigate the causal relationship between 91 inflammatory proteins and Alzheimer's disease (AD) using a bidirectional Mendelian randomization (MR) approach.
- To identify specific inflammatory proteins that may influence AD risk.
- To generate novel hypotheses regarding AD's pathological mechanisms.
Main Methods:
- Utilized a bidirectional two-sample MR approach.
- Selected independent genetic variants for 91 inflammatory proteins and AD from large genome-wide association studies.
- Employed various MR methods including inverse-variance-weighted (IVW) and sensitivity analyses to ensure robustness.
Main Results:
- Elevated levels of tumor necrosis factor-beta (TNF-β) were significantly associated with reduced AD risk (OR = 0.917, p = 0.006).
- Elevated levels of interleukin-6 (IL-6) were significantly associated with reduced AD risk (OR = 0.941, p = 0.009).
- No significant causal impact of AD on the levels of the 91 selected inflammatory proteins was observed.
Conclusions:
- Higher circulating levels of TNF-β and IL-6 appear to have a protective effect against the development of Alzheimer's disease.
- These findings highlight a potential therapeutic avenue targeting specific inflammatory pathways in AD prevention or treatment.
More Related Videos
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
